NSCLC Biomarkers: Expert Insights on New Targets, Testing Options, and Personalized Treatment

Review expert guidance for oncologists and pathologists on testing for new and emerging predictive biomarkers to guide treatment of NSCLC with this on-demand Webcast and slides from a live CCO Webinar.

Share

Program Content

Activities

Targeted Therapy in NSCLC
Current and Emerging Biomarkers in Lung Cancer Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2020

Expires: October 12, 2021

Biomarker Testing in NSCLC
Key Strategies for Biomarker Detection in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2020

Expires: October 12, 2021

NSCLC Biomarkers EP
NSCLC Biomarkers ExpressPoints: Expert Insights on New Targets, Testing Options, and Personalized Treatment
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2020

Expires: October 20, 2021

Activities

NSCLC Biomarkers
NSCLC Biomarkers: Expert Insights on New Targets, Testing Options, and Personalized Treatment
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

cover img faculity

Lauren L. Ritterhouse, MD

Assistant Professor
Department of Pathology
Harvard Medical School
Associate Director
Center for Integrated Diagnostics
Department of Pathology
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.